BUY Piramal Pharma LimitedNuvama Wealth

byNuvama WealthHorizon: NA (inferred 1 year)4 Feb 2024via Institutional / Brokerage Research

Entry₹137.65Inferred
Target₹150
Total upside +8.97% (call closed)
Stop lossNot given
Exit₹1503 May 2024, 12:05 pm
Target hit+8.97%0.00%upside left

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

No assessed factors in this tip’s window yet.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.